Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.

Dellapasqua S, Bagnardi V, Balduzzi A, Iorfida M, Rotmensz N, Santillo B, Viale G, Ghisini R, Veronesi P, Luini A, Morra A, Goldhirsch A, Colleoni M.

Clin Breast Cancer. 2014 Feb;14(1):53-60. doi: 10.1016/j.clbc.2013.09.008. Epub 2013 Sep 27.

PMID:
24183613
2.

Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit?

Obedian E, Haffty BG.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):997-1003.

PMID:
10421532
3.

Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.

Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K.

Med Oncol. 2013;30(3):615. doi: 10.1007/s12032-013-0615-7. Epub 2013 Jun 1.

PMID:
23729267
4.

The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients.

Kiricuta IC, Willner J, Kölbl O, Bohndorf W.

Int J Radiat Oncol Biol Phys. 1994 Jan 15;28(2):387-93.

PMID:
8276654
5.

Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L.

Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):883-94.

PMID:
10863056
6.

Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.

Courdi A, Chamorey E, Ferrero JM, Hannoun-Lévi JM.

Radiother Oncol. 2013 Aug;108(2):259-65. doi: 10.1016/j.radonc.2013.06.028. Epub 2013 Jul 25.

PMID:
23891092
7.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group..

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
9.

Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.

Janni W, Rack B, Sommer H, Schmidt M, Strobl B, Rjosk D, Klanner E, Thieleke W, Gerber B, Friese K, Dimpfl T.

J Cancer Res Clin Oncol. 2003 Sep;129(9):503-10. Epub 2003 Jul 18.

PMID:
12884027
10.

Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemma.

Deo SV, Purkayastha J, Shukla NK, Raina V, Asthana S, Das DK, Rath GK.

J Assoc Physicians India. 2003 Mar;51:272-5.

PMID:
12839350
11.

Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.

Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, Mizukami Y.

Cancer. 1991 Nov 1;68(9):1918-25.

12.

The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.

Hetelekidis S, Schnitt SJ, Silver B, Manola J, Bornstein BA, Nixon AJ, Recht A, Gelman R, Harris JR, Connolly JL.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):31-4.

PMID:
10656369
13.
14.

Treatment outcome in breast cancer patients with ipsilateral supraclavicular lymph node metastasis at time of diagnosis: a review of the literature.

Grotenhuis BA, Klem TM, Vrijland WW.

Eur J Surg Oncol. 2013 Mar;39(3):207-12. doi: 10.1016/j.ejso.2012.11.002. Epub 2012 Dec 8. Review.

PMID:
23232205
15.

Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.

Gobardhan PD, Elias SG, Madsen EV, van Wely B, van den Wildenberg F, Theunissen EB, Ernst MF, Kokke MC, van der Pol C, Borel Rinkes IH, Wijsman JH, Bongers V, van Gorp J, van Dalen T.

Ann Surg Oncol. 2011 Jun;18(6):1657-64. doi: 10.1245/s10434-010-1451-z. Epub 2010 Dec 14.

16.

(18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.

Wang CL, Eissa MJ, Rogers JV, Aravkin AY, Porter BA, Beatty JD.

AJR Am J Roentgenol. 2013 May;200(5):1138-44. doi: 10.2214/AJR.12.8754.

PMID:
23617501
17.

[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].

Guan Y, Xu BH, Li Q, Zhang P, Zhao LM, Yuan P, Wang JY.

Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81. Chinese.

PMID:
18353207
18.

Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement.

Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G.

J Clin Oncol. 2005 Mar 1;23(7):1379-89.

PMID:
15735114
19.

Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.

Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M.

Acta Oncol. 2008;47(2):232-8.

PMID:
17924207
20.

Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.

Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV.

Cancer. 2004 Sep 15;101(6):1330-7.

Supplemental Content

Support Center